News

Tests have identified Nipah virus in two patients from India’s Kerala state, one of them an 18-year-old woman from Malappuram ...
HWASUN, July 7 (Yonhap) -- South Korea has developed the world's first recombinant protein-based anthrax vaccine, a major ...
Korea has developed the world's first recombinant protein-based anthrax vaccine, a major step toward self-sufficiency that ...
The US Advisory Committee on Immunization Practices voted in June to stop recommending certain kinds of flu vaccines, a ...
The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.
Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...
Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...
Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...
Moderna is preparing to test Health Secretary Robert F. Kennedy Jr.'s tougher vaccine policies with a combination flu-COVID ...
Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...
The CDC panel voted against an ingredient that the anti-vaccine movement has long targeted, while Arcadia was acquired by ...